发明名称 RNAi INHIBITION OF SERUM AMYLOID FOR TREATMENT OF GLAUCOMA
摘要 <P>PROBLEM TO BE SOLVED: To provide an interfering RNA that targets SAA mRNA, and thereby interferes with SAA mRNA expression. <P>SOLUTION: There is provided RNA interference for inhibition of serum amyloid A mRNA expression in glaucoma involving SAA expression. There is provided a method for attenuating expression of the serum amyloid A mRNA in an eye of a subject including a step of administering to the eye of the subject a composition comprising an effective amount of the interfering RNA having a length of 19 to 49 nucleotides and a pharmaceutically acceptable carrier, the interfering RNA comprising a sense nucleotide sequence, an antisense nucleotide sequence, and a region of at least near-perfect contiguous complementary of at least 19 nucleotides between the sense and antisense sequences. <P>COPYRIGHT: (C)2013,JPO&INPIT
申请公布号 JP2012193209(A) 申请公布日期 2012.10.11
申请号 JP20120157485 申请日期 2012.07.13
申请人 ALCON INC 发明人 CLARK ABBOTT F;WANG WAN-HENG;MCNATT LORETTA
分类号 A61K31/7088;A61K48/00;A61P27/02;A61P27/06;A61P43/00;C12N15/113 主分类号 A61K31/7088
代理机构 代理人
主权项
地址